top of page
Sintalica develops breakthrough treatments for neuroinflammatory diseases
4MXPZIZA9kXjFtw05cQoGbbkzow1706626668469_200x200.png

Sintalica is a drug discovery company focused on Psilocybin and tryptamine derivatives for psychedelic-assisted therapies for a variety of targeted health conditions.

We are uniquely specialized in proprietary synthesizing psychedelics, formulating drugs, and developing new treatments.

 

Our team of experienced professionals stays current about the latest drug developments.

​

​

ABOUT

10+

U.S. FILED PATENTS

IP Portfolio Protecting
Novel Compounds and Formulations. 

30+

 BILLION COMPOUNDS SCREENED

 Leading AI-Enhanced Drug Development 

4

FEDERAL RESEARCH GRANTS RECEIVED

Maximizing R&D While Reducing Traditional Costs.

OUR APPROACH TO R&D

Artboard 1.png
SCIENTIFIC TEAM

Our scientific team is led by world-class experts in neurodegenerative diseases, pharmacology and chemistry.

We are specialized in developing novel proprietary psychedelic molecules resulting in more controlled and safer experiences, and no hallucinogenic effects. Our intellectual property is secured.

EXCLUSIVE PARTNERSHIP

Through our exclusive partnership with the University of Messina we discover, synthesize and trial novel psychedelics molecules in one place.

​

We have full expertise in drug and clinical development, regulatory affairs and psychedelic-specific manufacturing. 

FFF.png
OUR FOCUS

Scientific studies show that certain psychedelic molecules have powerful anti-inflammatory properties. Our proprietary molecules can help control peripheral and central neuroinflammation without hallucinogenic effects. 

SERVICES
THE TEAM
University bust statue

BOARD OF DIRECTORS

BRUCE LINTON

Co-Founder & Chairman 

FABIAN MONACO

Board Member

 JOHN DiGIROLAMO

Board Member

Traditional Library

EXECUTIVE TEAM

image_edited.png
JARED RHINES
MBA

Chief Executive Officer

image_edited.png
GEORGE JACKOWSKI
PhD

Chief Science Officer

image_edited.png
PETER KAMPIAN
CPA,CA,ICD.D

Chief Financial Officer

image_edited.png
ROHIT RAMCHANDANI
DrPH, MPH
​

Innovation

san.png
SANTINO BERNAUDO
B.A

Business Development

CLIENTS
Laboratory

STRATEGIC PARTNERSHIPS

image.png
image.png
image.png
image.png
bottom of page